Pelvic discomfort
(UMLS:C1535975)
- UMLS ID:
- C1535975
- MeSH ID:
- N/A
Synonym(s)
1.
Pelvic discomfort
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 145 Canada Vigilance: 7 | Canada Vigilance OFFSIDES US FAERS | |
| 2 | Copper | FAERS: 49 | US FAERS | |
| 3 | 17 alpha-Hydroxyprogesterone Caproate | FAERS: 13 | US FAERS | |
| 4 | NuvaRing | FAERS: 10 | SIDER US FAERS | |
| 5 | Octreotide | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Teriparatide | FAERS: 8 | US FAERS | |
| 7 | Estradiol | FAERS: 6 | US FAERS | |
| 8 | Varenicline | FAERS: 4 | US FAERS | |
| 9 | Dehydroepiandrosterone | FAERS: 3 | US FAERS | |
| 10 | Medroxyprogesterone Acetate | FAERS: 3 | US FAERS | |
| 11 | Ondansetron | FAERS: 3 | US FAERS | |
| 12 | niraparib | FAERS: 3 | US FAERS | |
| 13 | 4-hydroxybutyric acid | FAERS: 2 | US FAERS | |
| 14 | Baclofen | FAERS: 2 | US FAERS | |
| 15 | Ciprofloxacin | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Finasteride | FAERS: 2 | US FAERS | |
| 17 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 18 | Leuprolide | FAERS: 2 | US FAERS | |
| 19 | MDV 3100 | FAERS: 2 | US FAERS | |
| 20 | Oxycodone | FAERS: 2 | US FAERS | |
| 21 | Sertraline | FAERS: 2 | US FAERS | |
| 22 | mirabegron | FAERS: 2 | US FAERS | |
| 23 | rucaparib | FAERS: 2 | US FAERS | |
| 24 | Abiraterone Acetate | FAERS: 1 | US FAERS | |
| 25 | Afatinib | FAERS: 1 | US FAERS | |
| 26 | Alendronate | FAERS: 1 | US FAERS | |
| 27 | Alprazolam | FAERS: 1 | US FAERS | |
| 28 | Anastrozole | FAERS: 1 | US FAERS | |
| 29 | CID 129626832 | FAERS: 1 | US FAERS | |
| 30 | Clindamycin | FAERS: 1 | US FAERS | |
| 31 | Desvenlafaxine Succinate | FAERS: 1 | US FAERS | |
| 32 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 33 | Dutasteride | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 34 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 35 | Eszopiclone | FAERS: 1 | US FAERS | |
| 36 | FS 069 | FAERS: 1 | OFFSIDES US FAERS | |
| 37 | Lenalidomide | FAERS: 1 | OFFSIDES US FAERS | |
| 38 | Loperamide | FAERS: 1 | US FAERS | |
| 39 | Misoprostol | FAERS: 1 | US FAERS | |
| 40 | Ospemifene | FAERS: 1 | US FAERS | |
| 41 | Pregabalin | FAERS: 1 | US FAERS | |
| 42 | Qlaira | FAERS: 1 | US FAERS | |
| 43 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 44 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 45 | Sertraline | FAERS: 1 | US FAERS | |
| 46 | Tadalafil | FAERS: 1 | US FAERS | |
| 47 | Thyroxine | FAERS: 1 | US FAERS | |
| 48 | Toremifene | FAERS: 1 | US FAERS | |
| 49 | Vortioxetine hydrobromide | FAERS: 1 | US FAERS | |
| 50 | apixaban | FAERS: 1 | US FAERS | |
| 51 | carfilzomib | FAERS: 1 | US FAERS | |
| 52 | drospirenone and ethinyl estradiol combination | FAERS: 1 | US FAERS | |
| 53 | etonogestrel | FAERS: 1 | US FAERS | |
| 54 | obeticholic acid | FAERS: 1 | US FAERS | |
| 55 | oxybutynin | FAERS: 1 | OFFSIDES US FAERS | |
| 56 | palbociclib | FAERS: 1 | US FAERS | |
| 57 | tegaserod | FAERS: 1 | US FAERS | |
| 58 | Alendronate | OFFSIDES | ||
| 59 | Bortezomib | OFFSIDES | ||
| 60 | Butorphanol | OFFSIDES | ||
| 61 | Cephalexin | OFFSIDES | ||
| 62 | Clomiphene | SIDER | ||
| 63 | Doxycycline | OFFSIDES | ||
| 64 | Fosinopril | OFFSIDES | ||
| 65 | Imipramine | OFFSIDES | ||
| 66 | Methocarbamol | OFFSIDES | ||
| 67 | Methyltestosterone | OFFSIDES | ||
| 68 | Metronidazole | SIDER | ||
| 69 | Octreotide | OFFSIDES | ||
| 70 | Pamidronate | OFFSIDES | ||
| 71 | Raloxifene Hydrochloride | OFFSIDES | ||
| 72 | Sulfate | OFFSIDES | ||
| 73 | Thalidomide | OFFSIDES | ||
| 74 | Urofollitropin | SIDER | ||
| 75 | chlordiazepoxide, clidinium drug combination | OFFSIDES | ||
| 76 | tizanidine | OFFSIDES | ||
| 77 | treprostinil | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.